Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9M52
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,578
Award facts
- Contract value 100% obligated
- $13,577.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,577.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of December 9, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the DLA's Medical Supply Chain. The Ozempic procurement supports military healthcare programs and aligns with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries, which includes diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. The company's role as a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program demonstrates its capability to meet complex federal medical supply requirements through open competition, providing pharmaceutical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9M52?
SPE2DR26F9M52 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F9M52 worth?
The government has obligated $13,578 on SPE2DR26F9M52.
Is contract SPE2DR26F9M52 an order under another contract?
Yes. SPE2DR26F9M52 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9M52 competed?
The extent of competition for SPE2DR26F9M52 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award